These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26046929)

  • 1. Quantification of uptake and clearance of acyclovir in skin layers.
    Nair AB
    Antivir Ther; 2016; 21(1):17-25. PubMed ID: 26046929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection.
    Hasler-Nguyen N; Shelton D; Ponard G; Bader M; Schaffrik M; Mallefet P
    BMC Dermatol; 2009 Apr; 9():3. PubMed ID: 19341466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical delivery of acyclovir and ketoconazole.
    Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
    Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid.
    Klimowicz A; Farfał S; Bielecka-Grzela S
    J Clin Pharm Ther; 2007 Apr; 32(2):143-8. PubMed ID: 17381664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis.
    Morgan CJ; Renwick AG; Friedmann PS
    Br J Dermatol; 2003 Mar; 148(3):434-43. PubMed ID: 12653734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations.
    Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; De Clercq E; El-Shattawy HH
    J Pharm Sci; 1998 Aug; 87(8):917-21. PubMed ID: 9687333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products.
    Pensado A; Chiu WS; Cordery SF; Rantou E; Bunge AL; Delgado-Charro MB; Guy RH
    Pharm Res; 2019 Nov; 36(12):180. PubMed ID: 31728737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different BRIJ97 colloid systems as potential enhancers of acyclovir skin permeation and depot.
    Mazzotta E; Oliviero Rossi C; Muzzalupo R
    Colloids Surf B Biointerfaces; 2019 Jan; 173():623-631. PubMed ID: 30368209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin uptake and clearance of ciclopirox following topical application.
    Nair AB; Singh K; Al-Dhubiab BE; Attimarad M; Harsha S; Alhaider IA
    Biopharm Drug Dispos; 2013 Dec; 34(9):540-9. PubMed ID: 24123146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
    Jacob S; Nair AB; Al-Dhubiab BE
    J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis.
    Volpato NM; Nicoli S; Laureri C; Colombo P; Santi P
    J Control Release; 1998 Jan; 50(1-3):291-6. PubMed ID: 9685896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations.
    Shukla C; Friden P; Juluru R; Stagni G
    J Pharm Sci; 2009 Mar; 98(3):917-25. PubMed ID: 18623192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, Optimization and Evaluation of Organogel for Topical Delivery of Acyclovir.
    Bonde S; Mavani N; Bonde C
    Curr Drug Deliv; 2018; 15(3):397-405. PubMed ID: 29034838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.
    de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
    J Control Release; 2001 Jul; 75(1-2):191-7. PubMed ID: 11451509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical distribution of acyclovir in normal equine skin and equine sarcoids: An in vitro study.
    Haspeslagh M; Taevernier L; Maes AA; Vlaminck LE; De Spiegeleer B; Croubels SM; Martens AM
    Res Vet Sci; 2016 Jun; 106():107-11. PubMed ID: 27234546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of skin target site acyclovir concentrations following controlled (trans)dermal drug delivery in topical and systemic treatment of cutaneous HSV-1 infections in hairless mice.
    Imanidis G; Song WQ; Lee PH; Su MH; Kern ER; Higuchi WI
    Pharm Res; 1994 Jul; 11(7):1035-41. PubMed ID: 7937545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams.
    Mohammed YH; Namjoshi SN; Jung N; Windbergs M; Benson HAE; Grice JE; Raney SG; Roberts MS
    Pharm Res; 2024 Jul; 41(7):1507-1520. PubMed ID: 38955999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of percutaneous absorption of an acyclovir product using intact and tape-stripped human skin.
    Qureshi SA; Jiang M; Midha KK; Skelly JP
    J Pharm Pharm Sci; 1998; 1(3):102-7. PubMed ID: 10948397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
    Chen Y; Zahui T; Alberti I; Kalia YN
    Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.